AHA 2019 Focus On: Heart Failure and Diabetes

Study: Rising Trends in Worsening Outcomes Among Adults Hospitalized with Diabetes

There is a troubling upward trend of heart arrhythmias and acute myocardial infarctions (AMIs), especially in young male prediabetic individuals, according to findings from a new study presented at the American Heart Association 2019 Scientific Sessions in Philadelphia.
Rozlytrek vs. Vitrakvi: How Do These Cancer Drugs Compare?

Ceasing Methamphetamine Use Helps Reverse Drug-Induced Heart Failure

The use of methamphetamine (meth) can cause severe heart failure (HF) but stopping use can significantly improve according to the findings of a new study presented at the American Heart Association 2019 Scientific Sessions in Philadelphia.

Dapagliflozin Effective Across All Age Groups: DAPA-HF Analysis

Dapagliflozin is an effective treatment for patients with heart failure with reduced ejection fraction (HFrEF) across all age groups, according to the findings of a study presented at the American Heart Association 2019 Scientific Sessions in Philadelphia.
Patient Perceptions of Their Experience at Dialysis Center

Racial Bias and Discrimination May Negatively Impact Heart Care

Racial bias of ethnic minorities, specifically African Americans, factors into the decision-making process for approving patients with heart failure for heart transplants, according to the findings of two studies being presented at the American Heart Association’s Scientific Sessions 2019 in Philadelphia, PA.
Artificial Intelligence Can Accurately Examine Electrocardiograms and Predict Irregular Heartbeats

Artificial Intelligence Examining ECGs Predicts Irregular Heartbeat, Death Risk

Artificial intelligence can be used to accurately examine electrocardiogram (ECG) test results, according to the findings of two preliminary studies being presented at the American Heart Association’s Scientific Sessions 2019 in Philadelphia, PA.
Metabolic Surgery Reduces the Risk of Recurrent and Fatal Heart Attacks

Heart Disease and Cancer May Be Linked

The findings of a new study suggest that individuals who have survived heart attacks have an increased risk of developing cancer.
Racial Bias and Discrimination Negatively Impacts Heart Disease Care

ISCHEMIA: Invasive Strategy Yields No Risk Reduction in Ischemic Heart Disease Patients

New study results presented at the American Heart Association 2019 Scientific Sessions in Philadelphia suggest that an invasive interventional approach for treating stable ischemic heart disease yields no reduction in risk when compared to a less invasive approach.
HemOnc Round-Up: Kisqali® for the Treatment of Women with Advanced Breast Cancer, Age Disparities in Cancer Trial Participants, and More.

BETonMACE: Effect of BET Protein Inhibition with Apabetalone on Cardiovascular Outcomes in Patients with...

A study called the BETonMACE trial, which was presented at the American Heart Association’s Scientific Sessions 2019, tested the hypothesis that adding the use of apabetalone to standard of care therapies improves cardiovascular (CV) outcomes in patients with type 2 diabetes mellitus (T2DM) and low HDL-C after an acute coronary syndrome (ACS).
Study: Age, Sex, and BMI Plus Two Biomarkers Can Identify atrial fibrillation

DAPA-HF: The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial

The findings of the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) suggest that dapagliflozin is effective in the treatment of reduced ejection fraction (HFrEF) in patients with and without type 2 diabetes (T2D).
Cancer Patients Want to Give Consent Before Their Data is Used

What to Expect at the American Heart Association 2019 Scientific Sessions

PRESIDENTIAL SESSION – Tuesday, 12:45 pm This year’s presidential session, with remarks by American Heart Association CEO Nancy Brown, will...

Curated Journal Abstracts